Adverum Biotechnologies Cash from Financing (TTM) Analysis

Adverum Biotechnologies Inc (ADVM)

10.95 -0.20 (-1.79%) USD | NASDAQ | Apr 19, 11:24

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	0.069M
September 30, 2023	0.145M
June 30, 2023	0.25M
March 31, 2023	0.604M
December 31, 2022	0.607M
September 30, 2022	0.74M
June 30, 2022	0.74M
March 31, 2022	0.895M
December 31, 2021	2.397M
September 30, 2021	2.398M
June 30, 2021	206.65M
March 31, 2021	208.87M
December 31, 2020	355.98M
September 30, 2020	382.38M
June 30, 2020	178.04M
March 31, 2020	177.18M
December 31, 2019	28.19M
September 30, 2019	1.399M
June 30, 2019	1.475M
March 31, 2019	-0.219M
December 31, 2018	69.95M

Date	Value
September 30, 2018	86.62M
June 30, 2018	86.39M
March 31, 2018	86.36M
December 31, 2017	16.75M
September 30, 2017	0.306M
June 30, 2017	0.549M
March 31, 2017	0.481M
December 31, 2016	0.556M
September 30, 2016	0.078M
June 30, 2016	0.124M
March 31, 2016	0.147M
December 31, 2015	138.86M
September 30, 2015	138.63M
June 30, 2015	256.57M
March 31, 2015	303.42M
December 31, 2014	165.44M
September 30, 2014	166.93M
June 30, 2014	49.64M
March 31, 2014	3.18M
December 31, 2013	2.48M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.069M

Minimum

Dec 2023

382.38M

Maximum

Sep 2020

81.53M

Average

1.475M

Median

Jun 2019

Cash from Financing (TTM) Benchmarks